Dagmar Aimová

13 papers and 510 indexed citations i.

About

Dagmar Aimová is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Dagmar Aimová has authored 13 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Dagmar Aimová’s work include Cancer therapeutics and mechanisms (10 papers), Lung Cancer Research Studies (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Dagmar Aimová is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), Lung Cancer Research Studies (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Dagmar Aimová collaborates with scholars based in Czechia, Germany and United States. Dagmar Aimová's co-authors include Marie Stiborová, Eva Frei, Manfred Wießler, Jitka Poljaková, Jiřı́ Hudeček, Lucie Bořek-Dohalská, Volker M. Arlt, Andrea Breuer, Matthias Thiemann and Jan Sejbal and has published in prestigious journals such as Cancer Research, International Journal of Cancer and Carcinogenesis.

In The Last Decade

Co-authorship network of co-authors of Dagmar Aimová i

Fields of papers citing papers by Dagmar Aimová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagmar Aimová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Aimová. The network helps show where Dagmar Aimová may publish in the future.

Countries citing papers authored by Dagmar Aimová

Since Specialization
Citations

This map shows the geographic impact of Dagmar Aimová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Aimová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Aimová more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025